indications for semaglutide FDA has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for GLP-1 receptor agonists have revolutionized

Retatrutide is distinguished by its triple agonist activity across GLP-1, GIP, and glucagon receptors, allowing researchers to investigate multiple metabolic pathways within a single experimental framework

BissonABodinAFauchierGHerbertJAngoulvantDDucluzeauPHet alSex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis

When she was switched to semaglutide, a weekly GLP-1 agonist, the symptoms persisted for two additional months

However, noticeable changes such as weight loss or improved blood sugar control usually take 1 to 4 weeks to appear

KM: Even though plateaus are totally normal, they can be discouraging

Its important to understand that these dosing parameters come from rat studies and cannot be directly translated to human use without proper clinical trials